Search Thermo Fisher Scientific
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Invitrogen
Prostate Tumor Monoclonal Antibody (YPMA-2)
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Product Details
MA1-21390
Product Specifications
Species Reactivity
Human
Host/Isotype
Mouse
/ IgG3
Class
Monoclonal
Type
Antibody
Clone
YPMA-2
Immunogen
Membrane protein extracted from human prostate mucin tissues.
Conjugate
Form
Liquid
Concentration
1 mg/mL
Purification
Protein G
Storage buffer
PBS, pH 7.2
Contains
no preservative
Storage conditions
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Shipping conditions
Ambient (domestic); Wet ice (international)
RRID
AB_560737
Product Specific Information
This antibody reacts specifically with prostate mucin antigen. It does not react with fetal or benign prostate specimens, non-prostate carcinomas and normal human tissues.
Target Information
Prostate tumors, primarily arising as prostate cancer, are one of the most common malignancies in men. Prostate cancer develops in the prostate gland, which is responsible for producing seminal fluid. The onset of prostate cancer is often asymptomatic in its early stages, but as the disease progresses, symptoms such as difficulty in urination, pelvic pain, and blood in urine or semen may appear. Prostate cancer is typically a slow-growing tumor; however, some forms can be aggressive and metastasize to other parts of the body, particularly the bones and lymph nodes. The development of prostate cancer is influenced by genetic, environmental, and hormonal factors, with age being a significant risk factor. Diagnosis is commonly achieved through digital rectal exams (DRE), prostate-specific antigen (PSA) testing, and biopsy. Treatment options vary depending on the stage and aggressiveness of the tumor, ranging from active surveillance for low-risk cases to surgery, radiation therapy, hormonal therapy, and chemotherapy for more advanced stages.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
References (0)
Have you cited this product in a publication?
Let us know so we can reference it here.
Performance Guarantee
If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Learn more
We're here to help
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.
Contact tech support